Navigation Links
Highlights of NHLBI-supported research presented at American Heart Association's Scientific Sessions
Date:11/17/2009

with heart failure, angiotensin converting enzyme, also known as ACE, inhibitor therapy is common in many pediatric cardiac centers, but has never been tested systematically. ACE inhibitor therapy blocks an enzyme that leads to blood vessel constriction. In this study involving 230 infants, those treated with the ACE inhibitor enalapril were found to have no better growth rates or ventricular function at 14 months of age than infants treated with placebo. Infants in the enalapril and placebo groups registered similar results in a scoring system based on weight for age. With these latest results, researchers must now search for new options to help treat infants with this congenital heart defect. NHLBI Spokesperson: Gail Pearson, M.D., Sc.D. Study Investigator: Daphne T. Hsu, M.D., Division Chief, Pediatric Cardiology, Children's Hospital at Montefiore, can be reached at 917-842-5965 or dhsu@montefiore.org.


No significant cardiovascular differences between liberal and restrictive blood transfusion strategies in surgical hip repair patients. (Embargoed until 8 a.m. EST, Monday, Nov. 16) Patients undergoing hip fracture repair surgery may become anemic after surgery and require blood transfusions. Patients treated by a restrictive transfusion strategy had no significant differences in cardiovascular outcomes compared to similar patients treated with a liberal blood transfusion strategy, according to late-breaking clinical findings from Jeffrey L. Carson, M.D., of the University of Medicine and Dentistry of New Jersey's Robert Wood Johnson Medical School in New Brunswick, N.J. The study involved 2,016 patients, primarily women (75 percent) with a mean age of 81, who had surgery to repair a hip fracture. Some patients received transfusions as soon as their hemoglobin, proteins in the blood that carry iron, levels fell below 10 grams per deciliter (g/dL). Other patients were given blood transfusions o
'/>"/>

Contact: NHLBI Office of Communications
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
3. Other highlights in the September 11 JNCI
4. NEWSWEEK International Editions: Highlights and Exclusives, Oct. 1, 2007 Issue
5. Georgia Pecans Fit!: New Campaign Highlights Health Benefits, Recipes, Web Site
6. Highlights from the October 2007 Journal of the American Dietetic Association
7. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
8. NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue
9. Study Highlights Impact of Chronic Conditions on Working America
10. Report highlights inadequate pandemic planning as a threat to EU security
11. World Bank Group Report on Malaria in Africa Highlights Progress Towards Goal of Significantly Reducing Malaria Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , ... July 07, 2015 , ... Difass USA, a ... help pass those long, stressful days at work is knowing that there is hopefully ... laid back and stress free as imagined. Planning for a vacation can be quite ...
(Date:7/7/2015)... Angeles, CA (PRWEB) , ... July 07, 2015 ... ... International Business Times highlights rumors about possible facial rejuvenation that have emerged about ... year-old former U.S. Secretary of State looks more youthful than she has in ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today announced the ... helps active people find the most fun activities to do with friends. , The ... It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , “I’ve been ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... only industry group whose board is limited to permit holders. The Medical Cannabis ... how to move the industry forward and are committed to making sure patients ...
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team in Hong ... This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce but ... this initiative Cotton explained, “We send anything between 300 and 600 pieces of paper per ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2
... prepare for a day without cigarettes and tobacco products ... Smokeout (R) (November 21), new research gives them more ... to the American Academy of Otolaryngology-Head and Neck Surgery ... organization,s annual meeting in September 2008 are studies that ...
... Nelson, PhD, served as vice-chair of the advisory committee ... by the U.S. Department of Health and Human Services ... for Physical Activity and Nutrition and Associate Professor of ... Policy at Tufts. , "After reviewing a ...
... A further new multidisciplinary journal in the neurosciences, ... March 2009. With this addition to its publishing ... of research, current practices and future trends in the ... the gap between the life sciences, social sciences, engineering, ...
... Institute have found that reducing the levels of vascular endothelial ... of new blood vessel growth, in adult mice causes the ... retina that are essential to visual function. This finding, published ... implications for the chronic use of promising new anti-VEGF drugs ...
... WOBURN, Mass., Nov. 3 Culbert Healthcare,Solutions, ... services firm, announced today that Norm Botsford ... the Strategic Services practice., Mr. Botsford ... Officer,at University Physicians Healthcare (UPH), the health ...
... Scientists at Schepens Eye Research,Institute have found that reducing ... best known as a stimulator of new blood,vessel growth, ... Muller,glia -- cells of the retina that are essential ... 2008 PLoS ONE, holds implications for,the chronic use of ...
Cached Medicine News:Health News:Smokers see decline in ability to smell, rise in laryngitis, and upper airway issues 2Health News:Tufts' Nelson a leader on Physical Activity Guidelines advisory committee 2Health News:Springer launches Cognitive Computation 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 3Health News:Norm Botsford Joins Culbert Healthcare Solutions' Strategic Services Team 2Health News:Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution 2Health News:Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution 3
(Date:7/7/2015)... DUBLIN , June 30, 2015 ... has announced the addition of the "Deciphering ... Strategies" report to their offering. ... pharmaceutical companies have been involved in a series ... patent cliff has resulted in significant overcapacities in ...
(Date:7/7/2015)... , 7. Juli 2015 BioClinica®, ... für klinische Studien, gab heute bekannt, dass es ... Unternehmen bei Gewinnung und Erhalt von Patienten übernommen ... MediciGlobal , Ltd. und Access to Patients, ... einen Dienst zum Auffinden von Patienten, die für ...
(Date:7/7/2015)... July 7, 2015   InspireMD, Inc. ... leader in embolic protection systems ("EPS"), today announced ... System integrated with MicroNet ™ has received ... New Product Innovation Award.  Through active market research ... and consultants recognize the successful introduction of new ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5
... 17, 2010 Mylan Inc. (Nasdaq: MYL ) ... Inc. have been sued by Shionogi Pharma Inc. and CIMA ... New Drug Application (ANDA) with the U.S. Food and Drug ... mg, 15 mg and 30 mg. This product is the ...
... Dr. Marisa Weiss, president and founder of Breastcancer.org ... a letter to the U.S. Food and Drug Administration ... to review data for Avastin,s use in metastatic HER2-negative ... FDA has recommended removing Avastin,s approval to treat breast ...
Cached Medicine Technology:Mylan Confirms First-to-File Patent Challenge Relating to Orapred ODT® 2Non-Profit Breastcancer.org Shares Concerns with FDA on Avastin Breast Cancer Recommendation 2Non-Profit Breastcancer.org Shares Concerns with FDA on Avastin Breast Cancer Recommendation 3
...
Liquichek Hematology-16T Control is a hematology reference control used in monitoring determinations of blood cell values on TOA SYSMEX cell counters....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: